Euonymus alatus (Celastraceae) has been used as an anticancer agent in Korean traditional medicine. However, the potential bioactive contributors to the anticancer effects have not been thoroughly studied. Our screening test revealed that the MeOH extract of E. alatus twigs exhibited significant cytotoxicity against A549, SK-OV-3, and SK-MEL-2 cell lines. A bioassay-guided separation of the MeOH extract of E. alatus twigs resulted in the isolation and identification of 14 triterpenes as main phytochemicals. The structures of the compounds were elucidated on the basis of spectroscopic evidence as lupeol (1), betulin (2), 3β,28,30-lup-20(29)-ene triol (3), lupenone (4), betulone (5), 28,30-dihydroxy-3-oxolup-20(29)-ene (6), messagenin (7), glut-5-en-3β-ol (8), maslinic acid (9), hederagenin (10), 3-oxo-11α-methoxyolean-12-ene (11), 3β-hydroxy-1-oxo-olean-12-en-28-oic acid (12), ursolic acid (13), and 2α-hydroxyursolic acid (14). Of these compounds, 3, 6-8, and 10-14 were isolated for the first time from this plant. All isolated triterpenoids had consistent antiproliferative activities against A549, SK-OV-3, SK-MEL-2, and HCT-15 cell lines. Compounds 2, 5, and 7 showed significant cytotoxicity against all four cell lines tested, with IC 50 values of 3.26-8.61 μM.
Triterpenoids represent a large and diverse group of organic compounds characterized by the basic backbone of a 30-carbon isoprenoid molecule, and are ubiquitously distributed throughout the plant kingdom [1] . Because of the growing importance of triterpenoids as a source of therapeutic medications for various chronic diseases, there have been many studies investigating the potential biological activities and possible molecular targets of natural triterpenoids as well as synthetic triterpenoids [2] [3] [4] [5] . Recent experimental evidence supports the beneficial effects of triterpenoids as potential agents for the prevention and treatment of various types of cancer [5, 6] . There is also convincing evidence in experimental animal models demonstrating the anti-carcinogenic effects of triterpenoids against several cancer types, mainly by modulating the pathways that contribute to cell proliferation and apoptosis [5, 6] .
Euonymus alatus (Thunb.) Sieb. (Celastraceae) is a deciduous and popular ornamental tree that is commonly known as winged euonymus. The cork cambium on the twigs of this tree, which is called 'gui-jun woo', has long been used to treat cancers in Korean traditional medicine [7] . Recently, pharmacological studies have supported the potential of E. alatus as an anticancer agent using a variety of bioactive evaluations in vivo and in vitro models [8] [9] [10] . Known bioactive constituents of E. alatus, including sesquiterpenes, sesquiterpene alkaloids, triterpenes, flavonoids, and phenolic compounds have been reported [11] [12] [13] [14] [15] . However, to the best of our knowledge, the bioactive compounds that contribute to its anticancer effects have not been completely studied.
The MeOH extract of E. alatus twigs showed significant cytotoxicity against A549, SK-OV-3, and SK-MEL-2 cell lines based on the results of a sulforhodamine B (SRB) bioassay [16, 17] . As part of a search for the antiproliferative constituents from the twigs of E. alatus, we previously reported on the isolation and identification of five new phenolic compounds with cytotoxicity as well as anti-neuroinflammatory activity [16] . In the course of our continuing search for anticancer compounds from E. alatus twigs, we further investigated the active constituents of its MeOH extract based on a bioactivity-guided isolation principle. In the present research, we report the isolation and structural elucidation of 14 triterpenes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) from the active CHCl 3 -soluble fraction as the main phytochemicals (Figure 1 ). The SRB bioassay was performed to evaluate the antiproliferative activities of compounds 1-14 by determining their inhibitory effects on human tumor cell lines A549, SK-OV-3, SK-MEL-2, and HCT-15. In addition, the structure-activity relationships (SAR) of the isolated triterpenoids on the antiproliferative effects were addressed in this study.
Based on the bioactivity-guided isolation principle, the methanolic crude extract of E. alatus twigs was fractionated to yield soluble fractions of n-hexane, CHCl 3 , n-BuOH, and water. As shown in Table 1 , the crude MeOH extract displayed significant cytotoxicity against A549, SK-OV-3, and SK-MEL-2 cells, with IC 50 values of 8.2, 6.6, and 8.4 μg/mL, respectively. Among the derived soluble fractions, the n-hexane and CHCl 3 soluble fractions had cytotoxicity against A549, SK-OV-3, and SK-MEL-2 cells, while the n-BuOH and water soluble fractions were inactive (IC 50 : >50.0 μg/mL) ( Table 1 ). The cytotoxic effect of the CHCl 3 soluble fraction (IC 50 value of 8.1-8.6 μg/mL) was higher than that of the n-hexane soluble faction (IC 50 value of 24.6-27.0 μg/mL), which led us to investigate the CHCl 3 soluble fraction for active compounds. Further fractionation of the CHCl 3 soluble fraction using column chromatography revealed that its derived fractions A1, A2, A3, and A4 showed considerable cytotoxic activity against the tested cell lines ( Table 1 ). The active fractions A1, A2, and A3 were consolidated, and the combined fraction was applied to RP-C 18 silica gel column chromatography, which further afforded seven active fractions; B1, B9, B10, and B12-B15 (Table 1) . Fraction A4 was subjected to a Sephadex LH-20 column, which provided additionally three active fractions; C3, C4, and C5. Semipreparative HPLC purification of the active fraction B1 yielded a lupane-type triterpene 4 and an oleanane-type triterpene 11. Similarly, the active fraction B9 afforded two lupane-type triterpenes 3 and 7, and a lupane-type triterpene 6 was isolated from the active fraction B10; an oleanane-type triterpene 8 from the active fraction B12; a lupane-type triterpene 5 from the active fraction B13; a lupane-type triterpene 2 from the active fraction B14; a lupane-type triterpene 1 and an ursane-type triterpene 13 from the active fraction B15. Finally, three oleanane-type triterpenes 9, 10, and 12 and an ursane-type triterpene 14 were obtained from the consolidated fractions C3, C4, and C5. The structures of the isolated triterpenoids 1-14 were unambiguously confirmed by spectroscopic methods, including 1 H NMR, 13 C NMR, 2D NMR, and MS analysis. The compounds were identified as lupeol (1) [18] , betulin (2) [19] , 3β,28,30-lup-20(29)-ene triol (3) [20] , lupenone (4) [21] , betulone (5) [22] , 28,30-dihydroxy-3-oxolup-20(29)-ene (6) [23] , messagenin (7) [24] , glut-5-en-3β-ol (8) [25] , maslinic acid (9) [26] , hederagenin (10) [27], 3-oxo-11α-methoxyolean-12-ene (11) [28] , 3β-hydroxy-1-oxo-olean-12-en-28-oic acid (12) [29] , ursolic acid (13) [30] , and 2α-hydroxyursolic acid (14) [26] by comparing their obtained spectroscopic data with previously reported values. To the best of our knowledge, compounds 3, 6-8, and 10-14 were isolated for the first time from this plant.
The sulforhodamine B cell proliferation assay was used to evaluate the antiproliferative activities of the isolated triterpenes 1-14 [17] , which were tested against four human tumor cell lines, including A549 (non-small cell lung carcinoma), SK-OV-3 (ovary malignant ascites), SK-MEL-2 (skin melanoma), and HCT-15 (colon adenocarcinoma). The IC 50 (the concentration that causing 50% inhibition of cell proliferation) values of each compound were determined and are summarized in Table 2 . The data demonstrated that all isolated triterpenoids displayed consistent antiproliferative activities against all of the cell lines with IC 50 values ranging from 3.3 to 27.5 μM, except that no cytotoxic effects were observed for compounds 8 and 11 against SK-OV-3, SK-MEL-2, and HCT-15 cells (IC 50 >30.0 μM). Especially, compounds 2, 5, and 7 showed the most potent cytotoxicity against all four cell lines with IC 50 values ranging from 3.3-8.6 μM. Three types of triterpenoids, including lupane-type (1-7), oleananetype (8-12), and ursane-type (13-14) triterpenoids were tested for their antiproliferative activities. It is interesting to note that the order of average cytotoxicity of the isolated triterpenoids from high to low can be listed as lupane-type > ursane-type > oleanane-type. Even though all the active triterpenes showed broad spectrum activity, compounds 2, 5, and 7 with a hydroxyl group at C-28 demonstrated the most significant cytotoxicity against all four cell lines tested. Other lupane-type triterpenes showed moderate antiproliferative activities. These results suggest that the presence of the hydroxyl group at C-28 on lupane-type triterpenoids seems to be necessary to exert a good antiproliferative activity. However, the presence of the hydroxyl group at C-30 on lupane-type triterpenoids might not always increase cytotoxic activity. New information about structure-activity relationship was obtained by comparing cytotoxicity of 1 with 4, 2 with 5, and 3 with 6, in which paired compounds have the same skeleton. This led to the information that the existence of a ketone group at C-3 on lupane-type triterpenoids induced cytotoxicity slightly more effectively than the existence of Antiproliferative triterpenoids from Euonymus alatus Natural Product Communications Vol. 10 (11) 2015 1931 a hydroxyl group at C-3. This may be associated with lipophilicity, and a higher lipophilicity may facilitate penetration through the lipophilic plasma membrane of the tumor cells, and subsequently, to a higher cytotoxicity [31] . On the other hand, oleanane-type triterpenes 8 and 11 showed selective cytotoxic effects against A549 weakly, while other compounds 9, 10, and 12 showed high cytotoxic activity against all of the tested cell lines. This led us to conclude that the presence of a carboxyl group at C-28 is essential for the cytotoxic activity of the oleanane-type triterpenes. The ursane-type triterpenes 13 and 14 exhibited moderate antiproliferative activities against four human tumor cell lines.
In the present study, the MeOH extract of E. alatus twigs was investigated to explore its antiproliferative constituents. All of the isolated triterpenes showed significant antiproliferative activity against A549, SK-OV-3, SK-MEL-2, and HCT-15 cell lines, which confirmed that the isolated triterpenoids represented a portion of the molecules associated with anticancer effects of E. alatus. In conclusion, our results strongly suggest that the MeOH extract of E. alatus twigs is a potential source of anticancer health products, which supports the ethnopharmacological use of E. alatus in Korean traditional medicine to treat various cancers.
Experimental
General experimental procedures: Optical rotations were measured on a Jasco P-1020 Polarimeter, IR spectra on a Bruker IFS-66/S FT-IR spectrometer, UV spectra on a Shimadzu UV-1601 UV-Visible spectrophotometer, and ESI mass spectra on an Applied Biosystems Mariner time-of-flight mass spectrometer with an electrospray interface. NMR spectra were recorded on a Varian UNITY INOVA 500 NMR spectrometer operating at 500 MHz ( 1 H) and 125 MHz ( 13 C), with chemical shifts given in ppm (δ). Semi-preparative highperformance liquid chromatography (HPLC) was performed using a Gilson 306 pump with a Shodex refractive index detector. Silica gel 60 (Merck, 230-400 mesh) and RP-C 18 silica gel (Merck, 230-400 mesh) were used for column chromatography (CC). The packing material for molecular sieve column chromatography was Sephadex LH-20. Merck precoated silica gel F 254 and RP-18 F 254s plates were used for thin layer chromatography (TLC). Compounds were detected on TLC either under UV light or by heating after spraying with anisaldehyde-sulfuric acid.
Plant material: E. alatus twigs were collected from Chungju, Chungcheongbuk-do, Korea, in March 2010. Samples of plant material were identified by one of the authors (K.R. Lee). A voucher specimen (SKKU 2010-3) has been deposited in the herbarium of the School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Extraction and isolation:
The finely chopped plant material (5.2 kg) was extracted with 80% aqueous MeOH two times (each 20 L × 4 h) under reflux and filtered. The filtrate was evaporated under vacuum to obtain a crude MeOH extract (220 g), which was suspended in distilled water (3.6 L) and then successively solventpartitioned with n-hexane, CHCl 3 , and n-BuOH, yielding 31, 11, and 35 g of residue, respectively. Each fraction was evaluated for cytotoxic activity against human tumor cell lines, A549, SK-OV-3, and SK-MEL-2 using the SRB bioassay [17] .
The CHCl 3 -soluble fraction (11 g) was separated by silica gel (230-400 mesh) CC [500 g, 5 × 55 cm, eluted with CHCl 3 -MeOH, 20:1 (1.5 L), 10:1 (1.5 L), and 1:1 (1.0 L)] to give 7 fractions (A1 -A7). Fractions A1, A2, and A3 were consolidated on the basis of TLC analysis, and the combined fraction (2.3 g) was applied to RP-C 18 silica gel (230-400 mesh, 150 g) CC using a gradient solvent system of MeOH-H 2 O (1:1 -4:1 -1:0) to give 16 sub-fractions (B1 -B16). Sub-fraction B1 (150 mg) was applied to a Sephadex LH-20 column using a solvent system of CH 2 Cl 2 -MeOH (1:1) to give 5 fractions (B1-1 -B1-5). Fraction B1-5 (45 mg) was purified by semi-preparative reversed-phase HPLC with a solvent system of MeOH-H 2 O (97:3, 700 mL, flow rate; 2 mL/min) to yield compounds 4 (5 mg, t R 16.5 min) and 11 (6 mg, t R 23.0 min). Subfraction B9 (78 mg) was purified by semi-preparative normal-phase HPLC using a solvent system of CHCl 3 -MeOH (45:1, 500 mL, flow rate; 2 mL/min) to give compounds 3 (13 mg, t R 15.3 min) and 7 (5 mg, t R 12.1 min). Sub-fraction B10 (40 mg) was also separated by HPLC purification with a solvent system of CHCl 3 -MeOH (45:1, 500 mL, flow rate; 2 mL/min) to afford compound 6 (15 mg, t R 13.0 min). Sub-fraction B12 (25 mg) was purified by semi-preparative normal-phase HPLC with a solvent system of CHCl 3 -MeOH (40:1, 500 mL, flow rate; 2 mL/min) to obtain compound 8 (4 mg, t R 11.5 min). Sub-fraction B13 (350 mg) was applied to a Sephadex LH-20 column with a solvent system of CH 2 Cl 2 -MeOH (1:1) to give 6 fractions (B13-1 -B13-6). Fractions B13-4 and B13-5 were consolidated, and the combined fraction (24 mg) was purified by semi-preparative normal-phase HPLC using n-hexane-EtOAc (4:1, 800 mL, flow rate; 2 mL/min) to yield compound 5 (5 mg, t R 17.6 min). Sub-fraction B14 (300 mg) was applied to a Sephadex LH-20 column using CH 2 Cl 2 -MeOH (1:1) to furnish 5 fractions (B14-1 -B14-5). Fractions B14-3 and B14-4 were combined, and the combined fraction (47 mg) was purified by semi-preparative normal-phase HPLC using n-hexane-EtOAc (3:1, 800 mL, flow rate; 2 mL/min) to give compound 2 (10 mg, t R 15.0 min). Fraction B15 (540 mg) was subjected to a Sephadex LH-20 column using CH 2 Cl 2 -MeOH (1:1) to obtain compound 1 (10 mg) and 3 fractions (B15-1 -B15-3). Fraction B15-2 (15 mg) was purified by semipreparative reversed-phase HPLC using MeOH-H 2 O (98:2, 700 mL, flow rate; 2 mL/min) to give compound 13 (8 mg, t R 17.3 min). Fraction A4 (1.2 g) was applied to a Sephadex LH-20 column with a solvent system of CH 2 Cl 2 -MeOH (1:1) to give 5 sub-fractions (C1 -C5). Sub-fractions C3, C4, and C5 were consolidated, and the combined fraction (640 mg) was applied to silica gel (230-400 mesh, 80 g) CC using a solvent system of CHCl 3 -MeOH (25:1) to yield 8 fractions (C3-1 -C3-8). Fractions C3-5, C3-6, and C3-7 were combined, and the combined fraction (65 mg) was purified by semi-preparative reversed-phase HPLC with a solvent system of MeOH-H 2 O (93:7, 700 mL, flow rate; 2 mL/min) to afford compounds 9 (6 mg, t R 17.5 min) and 14 (5 mg, t R 18.3 min). Finally, fraction C3-8 (150 mg) was filtered with a solvent system of MeOH-H 2 O (1:1), and the remaining residue (35 mg) was purified by HPLC with a solvent system of MeOH-H 2 O (93:7, 700 mL, flow rate; 2 mL/min) to give compounds 10 (4 mg, t R 15.0 min) and 12 (4 mg, t R 18.5 min).
Supplementary data: Physico-chemical properties and 13 C NMR data of compounds 1-14 and bioassay protocol are available in electronic form on the publisher's website.
